 Jacinda Nicklas
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 15 | 2025 | 306 | 3.850 |
Why?
| | Postpartum Period | 13 | 2025 | 373 | 2.560 |
Why?
| | Life Style | 13 | 2026 | 485 | 2.420 |
Why?
| | Metabolic Syndrome | 7 | 2026 | 360 | 1.710 |
Why?
| | Depression, Postpartum | 5 | 2025 | 116 | 1.580 |
Why?
| | Obesity | 12 | 2026 | 3116 | 1.350 |
Why?
| | Diabetes Mellitus, Type 2 | 10 | 2023 | 2588 | 1.120 |
Why?
| | Weight Loss | 7 | 2026 | 858 | 1.090 |
Why?
| | Menopause | 2 | 2026 | 326 | 0.940 |
Why?
| | Overweight | 6 | 2024 | 614 | 0.920 |
Why?
| | Feeding Behavior | 3 | 2026 | 690 | 0.910 |
Why?
| | Food Assistance | 2 | 2023 | 29 | 0.790 |
Why?
| | Cardiovascular Diseases | 6 | 2024 | 2187 | 0.760 |
Why?
| | Pregnancy | 24 | 2025 | 7202 | 0.740 |
Why?
| | Exercise | 6 | 2026 | 2198 | 0.730 |
Why?
| | Bariatric Surgery | 1 | 2026 | 252 | 0.720 |
Why?
| | Body Mass Index | 12 | 2026 | 2445 | 0.630 |
Why?
| | Health Promotion | 4 | 2023 | 775 | 0.620 |
Why?
| | Metformin | 4 | 2024 | 329 | 0.580 |
Why?
| | Healthy Lifestyle | 1 | 2019 | 37 | 0.570 |
Why?
| | Feasibility Studies | 1 | 2023 | 1111 | 0.560 |
Why?
| | Metabolic Diseases | 1 | 2019 | 114 | 0.530 |
Why?
| | Behavior Therapy | 2 | 2024 | 296 | 0.510 |
Why?
| | Patient Discharge Summaries | 1 | 2017 | 10 | 0.500 |
Why?
| | Patient Selection | 2 | 2024 | 738 | 0.500 |
Why?
| | Waist Circumference | 4 | 2026 | 143 | 0.490 |
Why?
| | Adult | 30 | 2026 | 40777 | 0.480 |
Why?
| | Female | 40 | 2026 | 78844 | 0.480 |
Why?
| | Medical Records | 1 | 2017 | 192 | 0.470 |
Why?
| | Delivery, Obstetric | 1 | 2017 | 160 | 0.460 |
Why?
| | Prenatal Diagnosis | 1 | 2017 | 196 | 0.440 |
Why?
| | Boston | 4 | 2025 | 93 | 0.420 |
Why?
| | Anti-Obesity Agents | 2 | 2026 | 67 | 0.410 |
Why?
| | Dietary Carbohydrates | 2 | 2024 | 147 | 0.410 |
Why?
| | Diet, Reducing | 1 | 2013 | 91 | 0.370 |
Why?
| | Appetite Depressants | 1 | 2012 | 19 | 0.360 |
Why?
| | Humans | 43 | 2026 | 145474 | 0.360 |
Why?
| | Dietary Proteins | 1 | 2013 | 135 | 0.350 |
Why?
| | Patient Transfer | 2 | 2025 | 211 | 0.350 |
Why?
| | Dietary Fats | 1 | 2013 | 308 | 0.330 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2024 | 1419 | 0.320 |
Why?
| | C-Reactive Protein | 1 | 2013 | 422 | 0.320 |
Why?
| | Health Behavior | 3 | 2025 | 789 | 0.290 |
Why?
| | Ivermectin | 3 | 2024 | 15 | 0.290 |
Why?
| | Diet | 3 | 2025 | 1277 | 0.290 |
Why?
| | Fluvoxamine | 3 | 2024 | 18 | 0.290 |
Why?
| | Middle Aged | 18 | 2026 | 36215 | 0.280 |
Why?
| | Follow-Up Studies | 3 | 2026 | 5423 | 0.270 |
Why?
| | Weight Gain | 3 | 2018 | 561 | 0.260 |
Why?
| | Antiviral Agents | 2 | 2024 | 769 | 0.250 |
Why?
| | Internet | 4 | 2023 | 689 | 0.240 |
Why?
| | Risk Factors | 10 | 2025 | 10885 | 0.240 |
Why?
| | Mothers | 2 | 2022 | 765 | 0.230 |
Why?
| | Risk Reduction Behavior | 4 | 2026 | 217 | 0.230 |
Why?
| | Premenopause | 1 | 2026 | 125 | 0.220 |
Why?
| | Habits | 1 | 2025 | 52 | 0.220 |
Why?
| | Perimenopause | 1 | 2026 | 69 | 0.220 |
Why?
| | Pre-Eclampsia | 2 | 2020 | 206 | 0.220 |
Why?
| | Pandemics | 2 | 2024 | 1707 | 0.220 |
Why?
| | Depression | 3 | 2024 | 1546 | 0.210 |
Why?
| | Snacks | 1 | 2024 | 22 | 0.210 |
Why?
| | Obesity Management | 1 | 2023 | 12 | 0.200 |
Why?
| | Appetite | 1 | 2024 | 80 | 0.200 |
Why?
| | Preconception Care | 1 | 2024 | 50 | 0.200 |
Why?
| | Live Birth | 1 | 2024 | 81 | 0.200 |
Why?
| | Postmenopause | 1 | 2026 | 392 | 0.200 |
Why?
| | Workload | 1 | 2025 | 168 | 0.190 |
Why?
| | Trust | 1 | 2025 | 155 | 0.190 |
Why?
| | Treatment Outcome | 6 | 2026 | 11772 | 0.190 |
Why?
| | Fertility | 1 | 2024 | 173 | 0.180 |
Why?
| | Blood Glucose | 5 | 2026 | 2341 | 0.180 |
Why?
| | Mass Screening | 2 | 2024 | 1360 | 0.180 |
Why?
| | Body Weight | 2 | 2019 | 971 | 0.180 |
Why?
| | Viral Load | 1 | 2024 | 526 | 0.180 |
Why?
| | Young Adult | 6 | 2024 | 14218 | 0.180 |
Why?
| | Health Equity | 1 | 2024 | 133 | 0.180 |
Why?
| | Perception | 1 | 2025 | 378 | 0.180 |
Why?
| | Cross-Over Studies | 1 | 2024 | 608 | 0.170 |
Why?
| | Internal Medicine | 1 | 2024 | 279 | 0.170 |
Why?
| | Qualitative Research | 3 | 2025 | 1674 | 0.170 |
Why?
| | Interviews as Topic | 4 | 2025 | 910 | 0.160 |
Why?
| | Self Report | 1 | 2025 | 870 | 0.160 |
Why?
| | Glucose Tolerance Test | 2 | 2023 | 360 | 0.160 |
Why?
| | Maternal Health Services | 1 | 2021 | 101 | 0.150 |
Why?
| | Male | 14 | 2026 | 72842 | 0.150 |
Why?
| | Poverty | 1 | 2023 | 526 | 0.150 |
Why?
| | Cardiovascular System | 1 | 2020 | 138 | 0.140 |
Why?
| | Sex Factors | 1 | 2024 | 2105 | 0.140 |
Why?
| | Insulin | 2 | 2024 | 2512 | 0.140 |
Why?
| | Racism | 1 | 2021 | 146 | 0.140 |
Why?
| | Obstetrics | 1 | 2020 | 177 | 0.140 |
Why?
| | Biomarkers | 2 | 2024 | 4295 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2024 | 935 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2024 | 735 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 477 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1891 | 0.130 |
Why?
| | Child Development | 1 | 2021 | 483 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2025 | 1146 | 0.120 |
Why?
| | Aged | 8 | 2025 | 26153 | 0.120 |
Why?
| | Anxiety | 1 | 2024 | 1118 | 0.120 |
Why?
| | Focus Groups | 3 | 2015 | 569 | 0.110 |
Why?
| | Double-Blind Method | 3 | 2024 | 2062 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2013 | 330 | 0.090 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2024 | 149 | 0.090 |
Why?
| | Preventive Health Services | 1 | 2014 | 153 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2017 | 586 | 0.090 |
Why?
| | Infant | 2 | 2024 | 10077 | 0.090 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 277 | 0.090 |
Why?
| | Cesarean Section | 1 | 2013 | 230 | 0.090 |
Why?
| | Fasting | 1 | 2013 | 279 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2021 | 17291 | 0.080 |
Why?
| | Cholesterol | 1 | 2013 | 408 | 0.080 |
Why?
| | Odds Ratio | 1 | 2013 | 1082 | 0.080 |
Why?
| | Adolescent | 3 | 2019 | 22529 | 0.080 |
Why?
| | Program Evaluation | 1 | 2014 | 943 | 0.080 |
Why?
| | Indians, North American | 1 | 2015 | 597 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2022 | 531 | 0.080 |
Why?
| | Prognosis | 1 | 2018 | 4316 | 0.070 |
Why?
| | Body Composition | 1 | 2013 | 693 | 0.070 |
Why?
| | Adipose Tissue | 1 | 2013 | 645 | 0.070 |
Why?
| | Adiposity | 1 | 2013 | 532 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1048 | 0.070 |
Why?
| | Blood Pressure | 2 | 2026 | 1779 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 881 | 0.070 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1323 | 0.060 |
Why?
| | Social Support | 1 | 2011 | 646 | 0.060 |
Why?
| | United States | 3 | 2025 | 16098 | 0.060 |
Why?
| | Remission Induction | 1 | 2026 | 307 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2026 | 318 | 0.050 |
Why?
| | Peptide YY | 1 | 2024 | 28 | 0.050 |
Why?
| | Health Information Exchange | 1 | 2024 | 23 | 0.050 |
Why?
| | Gastric Balloon | 1 | 2023 | 17 | 0.050 |
Why?
| | Child | 1 | 2024 | 22707 | 0.050 |
Why?
| | Postprandial Period | 1 | 2024 | 114 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 81 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2024 | 219 | 0.050 |
Why?
| | Propiophenones | 1 | 2023 | 1 | 0.050 |
Why?
| | Fruit | 1 | 2024 | 146 | 0.050 |
Why?
| | Nitro Compounds | 1 | 2023 | 8 | 0.050 |
Why?
| | Vegetables | 1 | 2024 | 161 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 118 | 0.050 |
Why?
| | Infertility, Female | 1 | 2024 | 122 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2025 | 554 | 0.040 |
Why?
| | New Zealand | 1 | 2021 | 54 | 0.040 |
Why?
| | Patient Health Questionnaire | 1 | 2021 | 40 | 0.040 |
Why?
| | Eating | 1 | 2024 | 387 | 0.040 |
Why?
| | Energy Intake | 1 | 2024 | 512 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 6013 | 0.040 |
Why?
| | Reimbursement, Incentive | 1 | 2021 | 42 | 0.040 |
Why?
| | Parturition | 1 | 2021 | 68 | 0.040 |
Why?
| | Hospitalists | 1 | 2024 | 267 | 0.040 |
Why?
| | Outpatients | 1 | 2023 | 447 | 0.040 |
Why?
| | Triglycerides | 1 | 2021 | 520 | 0.040 |
Why?
| | Age Factors | 1 | 2026 | 3342 | 0.030 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 440 | 0.030 |
Why?
| | Peptides | 1 | 2023 | 998 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 446 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1747 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2021 | 776 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11853 | 0.030 |
Why?
| | Incidence | 1 | 2023 | 2923 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2024 | 1101 | 0.030 |
Why?
| | Physicians | 1 | 2024 | 955 | 0.030 |
Why?
| | Oklahoma | 1 | 2015 | 22 | 0.030 |
Why?
| | Hypertension | 1 | 2023 | 1273 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1199 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2865 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1426 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2953 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2021 | 946 | 0.030 |
Why?
| | Risk Assessment | 2 | 2013 | 3747 | 0.020 |
Why?
| | Women's Health | 1 | 2015 | 314 | 0.020 |
Why?
| | Food | 1 | 2013 | 150 | 0.020 |
Why?
| | Text Messaging | 1 | 2015 | 182 | 0.020 |
Why?
| | Family Characteristics | 1 | 2013 | 195 | 0.020 |
Why?
| | Patient Preference | 1 | 2013 | 223 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 8057 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2460 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2022 | 8333 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5904 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 7123 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6066 | 0.010 |
Why?
|
|
Nicklas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|